JP2019508184A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508184A5
JP2019508184A5 JP2018548904A JP2018548904A JP2019508184A5 JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5 JP 2018548904 A JP2018548904 A JP 2018548904A JP 2018548904 A JP2018548904 A JP 2018548904A JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5
Authority
JP
Japan
Prior art keywords
solution
self
assembling peptide
hydrogel
assembling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018548904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508184A (ja
JP7049557B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000312 external-priority patent/WO2017158420A1/en
Publication of JP2019508184A publication Critical patent/JP2019508184A/ja
Publication of JP2019508184A5 publication Critical patent/JP2019508184A5/ja
Application granted granted Critical
Publication of JP7049557B2 publication Critical patent/JP7049557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018548904A 2016-03-18 2017-03-17 生物組織の癒着の予防 Active JP7049557B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662310131P 2016-03-18 2016-03-18
US201662310121P 2016-03-18 2016-03-18
US62/310,131 2016-03-18
US62/310,121 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (3)

Publication Number Publication Date
JP2019508184A JP2019508184A (ja) 2019-03-28
JP2019508184A5 true JP2019508184A5 (enExample) 2020-04-23
JP7049557B2 JP7049557B2 (ja) 2022-04-07

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018548904A Active JP7049557B2 (ja) 2016-03-18 2017-03-17 生物組織の癒着の予防

Country Status (11)

Country Link
US (4) US20190091376A1 (enExample)
EP (1) EP3429653B1 (enExample)
JP (1) JP7049557B2 (enExample)
KR (1) KR20190022455A (enExample)
CN (1) CN109152868A (enExample)
AU (2) AU2017232540A1 (enExample)
BR (1) BR112018068941A2 (enExample)
CA (1) CA3017684A1 (enExample)
CL (1) CL2018002646A1 (enExample)
MX (1) MX2018011121A (enExample)
WO (1) WO2017158420A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
US11534528B2 (en) 2020-03-31 2022-12-27 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843776A4 (en) * 2004-07-06 2011-05-11 3D Matrix Inc PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20080007380A (ko) * 2005-04-25 2008-01-18 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
ES2694000T3 (es) * 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
WO2013030673A2 (en) * 2011-09-02 2013-03-07 3-D Matrix, Ltd. Amphiphilic peptides for thoracic air leakage occlusion
JP2016501066A (ja) * 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
WO2017158435A1 (en) 2016-03-18 2017-09-21 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
BR112018068838A2 (pt) 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de fístula pancreática

Similar Documents

Publication Publication Date Title
JP2019508184A5 (enExample)
JP2024100934A (ja) 液体送達組成物
WO2017028025A1 (zh) 贻贝粘蛋白产品及其抑制粘膜炎症的应用
JP6438406B2 (ja) 疎水性生理活性物質を送達するための組成物および方法
JP5954736B2 (ja) 難治性炎症性腸疾患の予防又は治療方法
JP2014221830A5 (enExample)
JP6837598B2 (ja) コラーゲンペプチドに基づく医薬組成物及びデバイス、並びにその製造の方法及び使用
JP2023109937A (ja) 3-置換1,2,4-オキサジアゾールの結晶形態
Naveed et al. A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management
WO2024016002A1 (en) Milk derived exosomes and uses thereof
JP2019508175A5 (enExample)
RU2615767C2 (ru) Способ лечения сердечной недостаточности и поражения нервных клеток
EP4392019A1 (en) Endoscopic, percutaneous and other methods for dissolution of pancreatic necrosis
CN101822643B (zh) 川芎嗪纳米粒及其制备方法和制药中的应用
CN105497019A (zh) 胺类化合物治疗疼痛的医药用途
WO2017181978A1 (zh) 贻贝粘蛋白产品及其抑制血管炎症的应用
JP5936683B2 (ja) 癒着の治療及び予防のための化合物、医薬組成物及び方法
US20220184110A1 (en) Esophageal stricture suppressing agent
CN113150067B (zh) Gsdme抑制剂及其在肿瘤化疗诱导的消化道损伤防治中的用途
US20100305144A1 (en) Prevention of recurrence of urethral stricture after a conventional treatment
PL235226B1 (pl) Ksantohumol do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych oraz kompozycja zawierająca ksantohumol
RU2328298C1 (ru) Способ лечения неспецифического язвенного колита
US20080004222A1 (en) Antitumorigenic Drug Combination
Keller et al. Phenylephrine-induced epistaxis in a six-year-old Quarter horse with nephrosplenic entrapment
RU2711658C1 (ru) Способ лечения наружного генитального эндометриоза